Stay updated on Omalizumab in Multi-Allergen OIT Clinical Trial
Sign up to get notified when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.

Latest updates to the Omalizumab in Multi-Allergen OIT Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check20 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.0%

- Check35 days agoChange DetectedChanged the label for the update timestamp from 'Last Update Posted (Estimated)' to 'Last Update Posted' on the study record. This alters how update times are displayed but does not affect the underlying study data or eligibility criteria.SummaryDifference0.0%

- Check43 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded a Locations section listing study sites by state (Arkansas, California, Colorado, Georgia, Maryland, Massachusetts, New York, North Carolina, Pennsylvania, Texas) and updated the revision to v3.3.3.SummaryDifference0.7%

- Check93 days agoChange DetectedPublication section updated: added language that publications are provided voluntarily by the person entering information, and the revision label updated to v3.3.2 (replacing the previous phrasing about the study results). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Omalizumab in Multi-Allergen OIT Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Omalizumab in Multi-Allergen OIT Clinical Trial page.